- February 08, 2012
- 09:59 PM CET
- search
- T&C's
- Disclaimer
- PRIVACY POLICY
- Imprint
- RSS
- ©2012 EVOTEC
Evotec - Research never stops
- Loading...
Archive
Oct 16, 2007
Evotec Reports Positive Top-Line Results in Phase II Study with EVT 201 in Elderly Insomniacs with Daytime Sleepiness
Sep 11, 2007
Evotec Sells its Chemical Development Business to Aptuit for GBP 31.5m (approx. EUR 46.4m; US$ 63.9m) in Cash
Sep 05, 2007
Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia with EVT 201
Jul 17, 2007
Evotec Announces the Expansion of its GMP Sterile Pharmaceutical Manufacturing Facility
Jul 11, 2007
Evotec and Research Support International Limited Announce the Formation of Evotec-RSIL Ltd, a Joint Venture for the Design, Synthesis, Management and Commercialisation of Compound Libraries
Jun 13, 2007
Evotec Enhances its Fragment-Based Drug Discovery Business by the Addition of NMR Screening Assets from Combinature
Jun 04, 2007
Evotec Reports Positive Proof-of-Concept Top-Line Results with Insomnia Drug Candidate EVT 201
May 21, 2007
Evotec to Launch its First Innovation Centre for Fragment Based Drug Discovery
May 10, 2007
Panacos Extends Medicinal Chemistry Contract with Evotec into Fourth Year and Expands into Development Chemistry
Mar 19, 2007
Evotec and Boehringer Ingelheim Enter into Target Discovery Collaboration in Alzheimer's Disease
Feb 28, 2007
Evotec and Interprotein Sign Collaboration Agreement to Develop Interleukin 6 Inhibitors to Treat Inflammatory Diseases
Jan 22, 2007